KALA BIO, INC. Earnings Per Share, Basic and Diluted
KALA BIO, INC. (KALA) reported Earnings Per Share, Basic and Diluted of -$0.43 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-15
- KALA BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.43.
- KALA BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.57.
- KALA BIO, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.49.
- KALA BIO, INC. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.55.
- KALA BIO, INC. earnings per share, basic and diluted for fiscal 2020 was -$1.99.
- KALA BIO, INC. earnings per share, basic and diluted for fiscal 2019 was -$2.76.
- KALA BIO, INC. earnings per share, basic and diluted for fiscal 2018 was -$2.49.
- KALA BIO, INC. earnings per share, basic and diluted for fiscal 2017 was -$3.71.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2021-09-30 | -$0.43 10-Q · filed 2021-11-15 | -$1.00 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.49 10-Q · filed 2021-11-15 | -$2.03 derived: net income ÷ weighted average shares · filed 2022-11-08 | |
| 2021-06-30 | -$0.57 10-Q · filed 2021-08-05 | -$1.06 10-Q · filed 2021-08-05 | -$1.61 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$2.11 derived: net income ÷ weighted average shares · filed 2022-08-11 | |
| 2021-03-31 | -$0.49 10-Q · filed 2021-05-05 | -$1.04 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$1.54 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$1.96 derived: net income ÷ weighted average shares · filed 2022-05-16 | |
| 2020-12-31 | -$0.55 10-K · filed 2021-02-25 | -$1.05 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$1.46 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$1.99 10-K · filed 2021-02-25 | |
| 2020-09-30 | -$0.50 10-Q · filed 2021-11-15 | -$0.92 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$1.44 10-Q · filed 2021-11-15 | -$2.03 derived: net income ÷ weighted average shares · filed 2021-11-15 | |
| 2020-06-30 | -$0.42 10-Q · filed 2021-08-05 | -$0.94 10-Q · filed 2021-08-05 | -$1.54 derived: net income ÷ weighted average shares · filed 2021-08-05 | -$2.18 derived: net income ÷ weighted average shares · filed 2021-08-05 | |
| 2020-03-31 | -$0.54 10-Q · filed 2021-05-05 | -$1.16 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$1.83 derived: net income ÷ weighted average shares · filed 2021-05-05 | -$2.53 derived: net income ÷ weighted average shares · filed 2021-05-05 | |
| 2019-12-31 | -$0.63 10-K · filed 2021-02-25 | -$1.31 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.01 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.76 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$0.68 10-K · filed 2021-02-25 | -$1.38 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.13 10-Q · filed 2020-11-05 | -$2.89 derived: net income ÷ weighted average shares · filed 2021-02-25 | |
| 2019-06-30 | -$0.70 10-K · filed 2021-02-25 | -$1.45 10-Q · filed 2020-08-06 | -$2.21 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.87 derived: net income ÷ weighted average shares · filed 2021-02-25 | |
| 2019-03-31 | -$0.75 10-K · filed 2021-02-25 | -$1.51 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.16 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.78 derived: net income ÷ weighted average shares · filed 2021-02-25 | |
| 2018-12-31 | -$0.76 10-K · filed 2020-02-12 | -$1.41 derived: net income ÷ weighted average shares · filed 2020-02-12 | -$2.02 derived: net income ÷ weighted average shares · filed 2020-02-12 | -$2.49 10-K · filed 2020-02-12 | |
| 2018-09-30 | -$0.63 10-K · filed 2020-02-12 | -$1.23 derived: net income ÷ weighted average shares · filed 2020-02-12 | -$1.69 10-Q · filed 2019-11-07 | -$2.14 derived: net income ÷ weighted average shares · filed 2020-02-12 | |
| 2018-06-30 | -$0.60 10-K · filed 2020-02-12 | -$1.06 10-Q · filed 2019-08-06 | -$1.51 derived: net income ÷ weighted average shares · filed 2020-02-12 | -$2.06 derived: net income ÷ weighted average shares · filed 2020-02-12 | |
| 2018-03-31 | -$0.46 10-K · filed 2020-02-12 | -$0.91 derived: net income ÷ weighted average shares · filed 2020-02-12 | -$1.46 derived: net income ÷ weighted average shares · filed 2020-02-12 | -$2.55 derived: net income ÷ weighted average shares · filed 2020-02-12 | |
| 2017-12-31 | -$0.46 10-K · filed 2019-03-12 | -$1.00 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$2.21 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$3.71 10-K · filed 2019-03-12 | -$6.11 10-K · filed 2018-04-02 |
| 2017-09-30 | -$0.56 10-K · filed 2019-03-12 | -$2.20 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$4.51 10-Q · filed 2018-11-08 | -$7.29 derived: net income ÷ weighted average shares · filed 2019-03-12 | |
| 2017-06-30 | -$9.30 10-K · filed 2019-03-12 | -$17.56 10-Q · filed 2018-08-09 | -$24.67 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$32.85 derived: net income ÷ weighted average shares · filed 2019-03-12 | |
| 2017-03-31 | -$8.26 10-K · filed 2019-03-12 | -$15.37 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$23.55 derived: net income ÷ weighted average shares · filed 2019-03-12 | -$31.89 derived: net income ÷ weighted average shares · filed 2019-03-12 | |
| 2016-12-31 | -$7.11 10-K · filed 2018-04-02 | -$15.29 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$23.63 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$28.07 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$8.18 10-K · filed 2018-04-02 | -$16.52 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$20.97 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$8.34 10-K · filed 2018-04-02 | -$12.79 10-Q · filed 2017-08-31 | |||
| 2016-03-31 | -$4.45 10-K · filed 2018-04-02 | ||||
| 2015-12-31 | -$14.89 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |